ResearcherCase Comprehensive Cancer CenterNo recent work listed

Davendra Sohal

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 3 (principal investigator on 3)
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2015: 1 trial · 2016: 2 trials

Trials 3

Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer Principal investigator NCT02383433 ↗
p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer Principal investigator NCT02847000 ↗
Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study Principal investigator NCT02345460 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jennifer Rachel Eads · 1 shared trial, 2016 · strength 0.19
- Trial Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer NCT02383433 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.